Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Successful closure of intractable tracheoesophageal fistula using a combination of a modified silicon stent and metallic stents.
Yata S, Kaminou T, Hashimoto M, Ohuchi Y, Sugiura K, Adachi A, Kawai T, Endo M, Takasugi S, Yamamoto S, Matsumoto K, Kodani M, Ihaya T, Suyama H, Ogawa T. Yata S, et al. Among authors: kodani m. Acta Radiol Short Rep. 2012 Mar 19;1(2):arsr.2012.110005. doi: 10.1258/arsr.2012.110005. eCollection 2012. Acta Radiol Short Rep. 2012. PMID: 23986832 Free PMC article.
Influence of ethanol-induced pulmonary embolism on hemodynamics in pigs.
Yata S, Hashimoto M, Kaminou T, Ohuchi Y, Sugiura K, Adachi A, Kawai T, Endo M, Takasugi S, Yamamoto S, Matsumoto K, Kodani M, Ihaya T, Takahashi M, Ito H, Ogawa T. Yata S, et al. Among authors: kodani m. Ann Card Anaesth. 2013 Oct-Dec;16(4):245-9. doi: 10.4103/0971-9784.119164. Ann Card Anaesth. 2013. PMID: 24107690
Efficacy of immune checkpoint inhibitors according to programmed cell death-ligand 1 expression in patients with non-small cell lung cancer and brain metastasis: A real-world prospective observational study.
Masuda T, Tsubata Y, Hata K, Horie M, Kiura K, Kanaji N, Inoue T, Kodani M, Yanai M, Yamaguchi K, Matsumoto N, Yamasaki M, Ishikawa N, Masuda K, Takigawa N, Kuyama S, Kubota T, Nishii K, Hotta K, Hattori N. Masuda T, et al. Among authors: kodani m. Thorac Cancer. 2024 Dec;15(34):2408-2417. doi: 10.1111/1759-7714.15469. Epub 2024 Oct 16. Thorac Cancer. 2024. PMID: 39415454 Free PMC article.
Phase II study of brigatinib in patients with ROS1 fusion-positive non-small-cell lung cancer: the Barossa study.
Niho S, Goto Y, Toyozawa R, Daga H, Ohashi K, Takahashi T, Tanaka H, Sakakibara-Konishi J, Hattori Y, Morise M, Kodani M, Ikeda T, Izumi H, Matsumoto S, Yoh K, Nomura S, Goto K. Niho S, et al. Among authors: kodani m. ESMO Open. 2024 Aug;9(8):103642. doi: 10.1016/j.esmoop.2024.103642. Epub 2024 Jul 16. ESMO Open. 2024. PMID: 39018589 Free PMC article. Clinical Trial.
ZP2 cleavage blocks polyspermy by modulating the architecture of the egg coat.
Nishio S, Emori C, Wiseman B, Fahrenkamp D, Dioguardi E, Zamora-Caballero S, Bokhove M, Han L, Stsiapanava A, Algarra B, Lu Y, Kodani M, Bainbridge RE, Komondor KM, Carlson AE, Landreh M, de Sanctis D, Yasumasu S, Ikawa M, Jovine L. Nishio S, et al. Among authors: kodani m. Cell. 2024 Mar 14;187(6):1440-1459.e24. doi: 10.1016/j.cell.2024.02.013. Cell. 2024. PMID: 38490181 Free article.
Clinical characteristics of patients treated with immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: CS-Lung-003 prospective observational registry study.
Kuribayashi T, Ohashi K, Nishii K, Ninomiya K, Tsubata Y, Ishikawa N, Kodani M, Kanaji N, Yamasaki M, Fujitaka K, Kuyama S, Takigawa N, Fujimoto N, Kubota T, Inoue M, Fujiwara K, Harita S, Takata I, Takada K, Okawa S, Kiura K, Hotta K. Kuribayashi T, et al. Among authors: kodani m. J Cancer Res Clin Oncol. 2024 Feb 12;150(2):89. doi: 10.1007/s00432-024-05618-4. J Cancer Res Clin Oncol. 2024. PMID: 38347279 Free PMC article.
A randomized phase II study of afatinib alone or combined with bevacizumab for treating chemo-naïve patients with non-small cell lung cancer harboring EGFR mutations.
Ninomiya T, Ishikawa N, Kozuki T, Kuyama S, Inoue K, Yokoyama T, Kanaji N, Yasugi M, Shibayama T, Aoe K, Ochi N, Fujitaka K, Kodani M, Ueda Y, Watanabe K, Bessho A, Sugimoto K, Oze I, Hotta K, Kiura K. Ninomiya T, et al. Among authors: kodani m. Lung Cancer. 2023 Oct;184:107349. doi: 10.1016/j.lungcan.2023.107349. Epub 2023 Aug 19. Lung Cancer. 2023. PMID: 37651927 Clinical Trial.
106 results